Montelukast

Leukotriene CysLT1 antagonist

Catalog No. SIH-538

0 out of 5 based on 0 customer ratings
CAS No. 151767-02-1
Molecular Formula C35H35ClNO3S • Na
SKU: SIH-538 Categories: ,

Clear
SIH-538-Montelukast-sodium-Chemical-Structure.png
Product Name Montelukast
Description

Leukotriene CysLT1 antagonist

Purity >98% (HPLC); NMR (conforms)
CAS No. 151767-02-1
Molecular Formula C35H35ClNO3S • Na
Molecular Weight 608.2
Field of Use Not for use in humans. Not for use in diagnostics or therapeutics. For in vitro research use only.

Properties

Storage Temperature -20ºC
Shipping Temperature Shipped Ambient
Product Type Antagonist
Solubility Soluble in DMSO (50 mg/ml), or water (30 mg/ml), or ethanol (60 mg/ml)
Source Synthetic
Appearance Powder
SMILES CC(C)(O)C(C=CC=C1)=C1CC[C@H](SCC2(CC2)CC([O-])=O)C3=CC(/C=C/C4=NC5=CC(Cl)=CC=C5C=C4)=CC=C3.[Na+]
InChI 1S/C35H36ClNO3S.Na/c1-34(2,40)30-9-4-3-7-25(30)13-17-32(41-23-35(18-19-35)22-33(38)39)27-8-5-6-24(20-27)10-15-29-16-12-26-11-14-28(36)21-31(26)37-29;/h3-12,14-16,20-21,32,40H,13,17-19,22-23H2,1-2H3,(
InChIKey LBFBRXGCXUHRJY-YBGTYPRZSA-M
Safety Phrases Classification:
D2A Very Toxic Material Causing Other Toxic Effects - Reproductive hazard
E Corrosive Material - Corrosive to skin

Hazard statement(s):
H318 Causes serious eye damage.
H361fd Suspected of damaging fertility. Suspected of damaging the unborn child.

Precautionary statement(s):
P280 Wear protective gloves/ eye protection/ face protection.
P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
Cite This Product Montelukast sodium (StressMarq Biosciences Inc., Victoria BC CANADA, Catalog # SIH-538)

Biological Description

Alternative Names 1-[[[(1R)-1-[3-(1E)-2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]-methyl]-cyclopropaneacetic acid, monosodium salt, Montelukast sodium, Montelukast monosodium salt, MK-0476, MK-476, KS-1087
Research Areas Immunology, Innate Immunity, Macrophage
PubChem ID 23663996
Scientific Background Montelukast sodium, a selective cysteinyl leukotriene receptor 1 (CysLT1) antagonist, is gaining attention in neuroscience for its neuroprotective and anti-inflammatory properties. Originally developed for asthma and allergic rhinitis, Montelukast has demonstrated the ability to cross the blood-brain barrier and modulate neuroinflammatory responses. In preclinical models, it has been shown to reduce blood-brain barrier disruption, inhibit leukocyte migration, and suppress seizure activity. These effects suggest potential therapeutic applications in neurodegenerative diseases such as Alzheimer's and Parkinson's, where inflammation and barrier dysfunction are key pathological features.

Product Images

<p>Chemical structure of Montelukast sodium (SIH-538), a Leukotriene CysLT1 antagonist. CAS #: 151767-02-1. Molecular Formula: C35H35ClNO3S • Na. Molecular Weight: 608.2 g/mol.</p>

Chemical structure of Montelukast sodium (SIH-538), a Leukotriene CysLT1 antagonist. CAS #: 151767-02-1. Molecular Formula: C35H35ClNO3S • Na. Molecular Weight: 608.2 g/mol.

Reviews

Reviews

There are no reviews yet.

Be the first to review “Montelukast”

Your email address will not be published. Required fields are marked *